Montreal Heart Institute
Montreal Heart Institute
Montreal, Quebec, Canada49 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation | Arrhythmias, Cardiac, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07175428 | |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | Arterial Occlusive Diseases, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07037433 | |
| BoxX-NoAF Clinical Trial | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-10-07 | NCT06989775 | |
| The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) | Arterial Occlusive Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, heart failure, myocardial ischemia, systolic heart failure, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT05427370 | |
| Hemiarch vs Extended Arch in Type 1 Aortic Dissection | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Dissection, Blood Vessel, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-09-28 | NCT03885635 | |
| Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance | Aneurysm, Aneurysm, Ascending Aorta, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Recruiting | Not applicable | 2026-09-28 | NCT03536312 | |
| Cardiac Sarcoidosis Multi-Center Prospective Cohort | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, cardiac sarcoidosis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis | Recruiting | Not stated | 2026-09-24 | NCT01477359 | |
| Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial | Arterial Occlusive Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 3 | 2026-09-23 | NCT07524335 | |
| PULSED AF Post-Approval Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2026-09-22 | NCT06578104 | |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) | Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06081894 | |
| Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation | Recruiting | Not stated | 2026-09-22 | NCT04088071 | |
| The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial | Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 3 | 2026-09-18 | NCT04284839 | |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-09-16 | NCT07037459 | |
| Ultrasound Evaluation of Fluid Tolerance and Fluid Responsiveness in Postoperative Cardiac Surgery Patients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperemia, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, cardiovascular disorder, kidney disorder, kidney failure, urinary system disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-08-28 | NCT07792707 | |
| Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Recruiting | Not applicable | 2026-08-28 | NCT07454980 | |
| OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 3 | 2026-08-21 | NCT07136012 | |
| Cryoablation for Monomorphic Ventricular Tachycardia | Sustained VT | Active, not recruiting | Not applicable | 2026-08-07 | NCT05675865 | |
| Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-04 | NCT07291635 | |
| Adductor Canal Block: Efficacy in Postoperative Pain Management for Cardiac Surgery | Coronary Artery Bypass Grafting (CABG) Surgery; Saphenectomy | Not yet recruiting | Phase 2 / Phase 3 | 2026-07-29 | NCT07732465 | |
| Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | acute myocardial infarction | Enrolling by invitation | Phase 3 | 2026-07-23 | NCT04957719 | |
| Cardiac Sarcoidosis Randomized Trial | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, cardiac sarcoidosis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis | Recruiting | Phase 3 | 2026-07-10 | NCT03593759 | |
| Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2026-07-08 | NCT03706833 | |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-06-26 | NCT04045665 | |
| Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation | Ventricular Dysfunction, Ventricular Dysfunction, Right, cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 2 | 2026-06-25 | NCT05450328 | |
| SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-06-02 | NCT04722250 |